Tomou Ekaterina-Michaela, Engler Olivier, Chrysargyris Antonios, Tzortzakis Nikolaos, Skaltsa Helen, Urmann Corinna
Section of Pharmacognosy and Chemistry of Natural Products, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.
Organic-Analytical Chemistry, Weihenstephan-Triesdorf University of Applied Sciences, Straubing, Germany.
Phytochem Anal. 2025 Jul;36(5):1570-1579. doi: 10.1002/pca.3531. Epub 2025 Apr 4.
The SARS-CoV-2 pandemic has revealed a deficiency in antiviral agents. Plants, traditionally used for respiratory infections, are valuable sources of antiviral compounds. Such a plant is the Sideritis L. taxa (mountain tea), traditionally used against cold and cough.
Accordingly, this study aimed to investigate the potential protective effects of dichloromethane extracts from Sideritis species against SARS-CoV-2.
Eight Sideritis extracts were tested in an in vitro pretreatment assay to assess the protective effect against SARS-CoV-2. Therefore, infectious virus particles were pre-incubated with the extract, then incubated with Vero E6 cells to finally measure cell viability as a surrogate for virus infection. Untargeted analyses (GC-MS and LC-PDA-HRESIMS) were performed to determine metabolite profiles.
Using an orthogonal approach that combines untargeted metabolomics and biological data from a screening assay, we characterized the phytochemical profiles of the different extracts and prioritized samples for targeted isolation. The dichloromethane extract of Sideritis cypria exhibited a notable protective effect. Untargeted analysis revealed coumarins as key compounds, with varying amounts across Sideritis species. Accordingly, fractionation of extract resulted in the isolation of two coumarin derivatives. Structure elucidation was performed using one- and two-dimensional nuclear magnetic resonance experiments. The coumarin, more abundant in S. cypria, demonstrated a slight protective effect in the SARS-CoV-2 pretreatment assay.
This study highlights the antiviral effects of Sideritis taxa, although further investigations are necessary to clarify the full potential of the herb. Additionally, the methodology presented herein can serve as a valuable resource for future phytochemical investigations focused on coumarin content within Sideritis genus.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)大流行暴露了抗病毒药物的不足。传统上用于治疗呼吸道感染的植物是抗病毒化合物的宝贵来源。铁角蕨属植物(山茶)就是这样一种植物,传统上用于治疗感冒和咳嗽。
因此,本研究旨在调查铁角蕨属植物二氯甲烷提取物对SARS-CoV-2的潜在保护作用。
在体外预处理试验中测试了八种铁角蕨提取物,以评估其对SARS-CoV-2的保护作用。因此,将感染性病毒颗粒与提取物预孵育,然后与非洲绿猴肾细胞(Vero E6)孵育,最终测量细胞活力作为病毒感染的替代指标。进行非靶向分析(气相色谱-质谱联用仪和液相色谱-光电二极管阵列-高分辨电喷雾电离质谱联用仪)以确定代谢物谱。
使用一种结合非靶向代谢组学和筛选试验生物学数据的正交方法,我们表征了不同提取物的植物化学特征,并对样品进行了优先排序以进行靶向分离。塞浦路斯铁角蕨的二氯甲烷提取物表现出显著的保护作用。非靶向分析表明香豆素是关键化合物,不同铁角蕨属植物中的含量各不相同。因此,对提取物进行分级分离得到了两种香豆素衍生物。使用一维和二维核磁共振实验进行结构解析。在塞浦路斯铁角蕨中含量较高的香豆素在SARS-CoV-2预处理试验中表现出轻微的保护作用。
本研究突出了铁角蕨属植物的抗病毒作用,尽管需要进一步研究以阐明该草药的全部潜力。此外,本文介绍的方法可为未来针对铁角蕨属植物中香豆素含量的植物化学研究提供有价值的资源。